Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation

Madhur K. Garg, Paul Weiss, Anand K. Sharma, Giridhar R. Gorla, Wainwright Jaggernauth, Ravindra Yaparpalvi, John DelRowe, Jonathan J. Beitler

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

We describe our experience with adjuvant high dose rate brachytherapy (Ir-192) (HDRB) in patients, who failed surgery and post-operative external radiation therapy. The salvage treatment consisted of excision of the keloid and wound closure followed by HDRB (15 Gy in three fractions given on three consecutive business days beginning the day of surgery). At the time of last follow up, 88% (15/17) of the keloids were without any evidence of recurrence.

Original languageEnglish (US)
Pages (from-to)233-236
Number of pages4
JournalRadiotherapy and Oncology
Volume73
Issue number2
DOIs
StatePublished - Nov 1 2004

Keywords

  • High dose rate brachytherapy
  • Keloids
  • Salvage radiation therapy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation'. Together they form a unique fingerprint.

  • Cite this